Arrhythmia Research Technology Inc. provided earnings guidance for the second quarter and six months ended June 30, 2013. For the quarter, the company expects revenues of $4,880,445 and net loss of $328,022.

For the six months, the company expects revenues of $10,523,634 and net loss of $333,692.